Actors competitiveness… - Observatoire des pôles de compétitivité

crunchkingofprussiaΒιοτεχνολογία

6 Δεκ 2012 (πριν από 5 χρόνια και 1 μήνα)

193 εμφανίσεις

Alsace Biovalley Competitiveness
Cluster


An overview

Nicolas Carboni

General Manager

March. 2009

Agenda



Clusters and competitiveness clusters
policy in France



Cluster approach for regional economic
development: the Alsacian illustration in
Life Sciences


Roots of Alsace Biovalley


What is Alsace Biovalley today


3 years of competitiveness cluster: lllustrating
results


Key learning

Clusters and «

Competitivness
clusters

» policy in France

Clusters…


A well known concept…


The 3 keys: Industry


Research Training


Pushed by M. Porter in the late 70’


Widely applied (competitiveness) and proven (Canada)




A key basis for the new French Industrial
policy



Launched in 2004


National Competition


Global & national competitiveness clusters recognized


The French Policy’s aims


Identifying

high
-
potential

clusters

and

focus

public

aids

on

them


avoiding

scattering

of

public

subsidies



Strengthening

the

link

between

research

&

industry


promoting

industry
-
driven

research

programs


developing

the

“triple

helix

relationship”

between

firms,

research

centres

and

higher

education

institutions



Developing

a

full

ecosystem


Education,

private

financing

(business

angels,

VC,

asso

)

IP

management,

entrepreneurship,

international

development,





Competitiveness clusters are…


A combination, within
a geographic area, of firms,
higher education centres and research units,


sharing a
common strategy

aimed at generating
synergies and leader positions
centred on co
-
operative R&D projects

between companies and
public research laboratories


in order to reach the
critical mass

needed for
international competitiveness and visibility in targeted
technological fields,


With
dedicated governance

and
public oversight

bodies.



A drastic change ?

… A radical change…


First

there

was

public

research



Focussed

on

developing

new

knowledge

and

technologies



Then


Research

becomes

a

source

of

innovation


Laws

of

1999

&

2002
:

fostering

technology

transfer,

spin
-
off,

public

incubators



BUT

industrial

policy

remains

separate



2004
:

Competitiveness

clusters

in

France
:

reconciling

Research

&

Innovation

strategy

with

industrial

strategy



Both

at

the

regional

and

national

levels


A

key

tool

for

alignment

and

coherence


Cultural changes are
needed in the corporate,
academic and institutional
worlds

Roots of Alsace Biovalley




Alsace Biovalley history


Dedicated approaches on industrial sectors: an
old choice of Alsace Region


1998: Creation of Alsace Biovalley

and Biovalley tri
-
national


A shock and an opportunity: merger Ciba Sandoz


A
political choice
:
acknowledging opportunities and
resources in life sciences


A
strategic choice
: the
tri
-
national dimension


A unique critical mass in Europe: from Basel to Fribourg &
Strasbourg



Workers & companies do not see borders: one employment
and industrial area


Alsace Biovalley: Coordinator of the tri
-
national network


Over
5 M


funding from INTERREG II & III


Maturation process needs
time…

Alsace Biovalley history


10 years for three level of maturity… and cumulative
activities


1998


2002: focus on the social network


Provide people with opportunities to meet and exchange


Develop identity and belonging



2002
-

2005: focus on international positioning and brand


Strong presence at international level, sophisticated communication
tool box


Be on the “radar screen”


First “services to members” related to international events


2005: Alsace labellized as World Class Competitiveness Cluster



2006
-

… : Focus on economic development


Serving actors
: companies, laboratories, training & education
centers…



…and serving the territory


Is 10 years too long ?

Clusters are anchored in the
territory


Key components


A
substrat
: Industry


Research
-

Training


A
collective dynamic
, supported by public bodies &
agencies



University has a pivotal role



World class research

as a source of technologies and
innovation


High quality research = dense industrial relations


Performing TTOs
: a fundamental connection towards
businesses


Professionalism AND resources


Adapted initial and continuous training
: Attract and
Retain


600

companies
(Pharma/
Biotech/MedTech)

40

000
employes

in LS

ABV Substrat: a unique industrial
density in the Upper Rhine Valley

FH
BB

12
universities and
academic centers
(SdV)



16

000

scientists



70

000

students…


And
Conectus
: a
unique
organisation

ABV substrat : World class research
& training

Alsace Biovalley landscape


Beyond Research & training organizations


4 universities & 3 engineering schools


Three national research operators (CNRS, INSERM, INRA)



A number of structures to support laboratories and
companies



Regional (and departmental…) economic development
agencies


Some generalists… and some specialists (photonics, image…)


Regional Innovation Agency


Regional
incubators


TTOs

and Conectus


ChamberS of Commerce & Industry


CEEI
: European Center for Enterprise & Innovation


All these organizations
have people on the field…



Alsace Biovalley Cluster


Vision, Governance, Strategy






What vision of a cluster ?


Competitivness cluster as a “ project factory”…


Collaborative R&D projects between companies and labs


Operating a label opening doors to funding



…or an engine to fuel a cluster dynamic in the
Region



Beyond collaborative R&D…


But a real service provided


Competitiveness cluster as a federator and
coordinator of key actors


As many other organization work with companies and labs


…and a tool for
structuring the territory


The first choice to make…

Governance as a key tool to ensure
integration in regional innovation system


Separating roles within the cluster


Actors
: companies, research laboratories, training and
education: a dedicated association, by and for actors


Agencies and organization

working on the field


Public
funders



The dedicated association coordinates the
cluster, but is not the cluster



Alsace Biovalley® is the brand

under which the cluster
operates


A high level group dedicated to prospective


Structuring the roadmap

Governance as a key tool to ensure
integration in regional innovation system



ABV Executive Committee: all agencies working
on the field are involved in the cluster
governance


ONE strategy and action plan

for the cluster


Shared

responsibility and accountability

in front of
(shared) public funders

Integration is key to
coherence

Shared, articulated and focussed
strategy


Strengthening competitiveness of actors though a set of
services


Support for collaborative R&D projects, representation at partnering,
matchmaking, strategic intelligence platform, information capsules…


Strengthening competitiveness & attractiveness of
territories



Developing a set of
technology platforms

for services


Developing and adapting
training programs


Developing
infrastructures


Ensure availability of
capital funding

throughout the chain


Strengthening international positioning, network and
visibility


Building a critical mass

to be attractive


Developing
cluster to cluster relationship

to expand the pool of
opportunities for our actors

Three years of Competitiveness Cluster in
Alsace


Illustrating Results






10 years objectives: 3 key indicators


Over 10 years


5000 jobs created
.






Doubling of PPPs



Creation of 90
companies


After 3 years


380 direct + 100
finalizing:
over 1400
total



Increase of 60%



Creation of
18
companies + 6
incubated

(over 50%
of incubation activity)


Actors competitiveness…: illustrating R&D
projects

ANUBIS

Coordinateur

IRCAD, place de l’hôpital,
Strasbourg (67)

luc.soler@ircad.u
-
strasbg.fr

+33 (0)3 88 11 91 10


Partenaires

LSIIT (UMR CNRS/ULP
7005), Illkirch (67)

Karl Storz Endoscope,
Roissy CDG, France

Tuttlingen, Allemagne

Budget

Total


Aides


7
,
09

M



1
,
79

M




Financeurs


DGE



3 ans

Le

projet

ANUBIS

vise

à

développer

la

chirurgie

transluminale,

chirurgie

consistant

à

réaliser

un

acte

chirurgical

sur

des

organes

en

passant

au

travers

des

voies

naturelles

telles

que

l’estomac

(transgastrique)

ou

le

vagin

(transvaginale)
.

Ce

développement

passe

par

la

création

de

nouveaux

outils

chirurgicaux

selon

deux

axes

:

les

outils

mécaniques

contrôlés

directement

par

le

chirurgien,

et

les

outils

robotisés
..




World

first

in

Surgery



New

generation

of

endoscopes




Start
-
up

created

Durée

Partenaires

Budget

Objectif

Premiers résultats

Positionner

la

France

et

l’Alsace

en

leader

mondial

de

la

chirurgie

trans
-
luminale

en

développant

de

nouveaux

outils

chirurgicaux

associés

à

une

formation

de

haut

niveau
.

Ambitions

Actors competitiveness: illustrating R&D
projects

dscreen


Sanofi
-
aventis signs a collaboration
agreement with RainDance
Technologies and Louis Pasteur
University to
launch dScreen
Consortium within Alsace BioValley
cluster



Raindance Technologies
chooses Strasbourg to create
its European affiliate

Actors competitiveness: illustrating
R&D projects

Physics, NICT, photonics, robotics, etc.

Life & chemical
sciences

36 project labellized and funded, over 90
partners, 130M$ of project costs over the past
three years

Actors competitiveness: illustrating
matching activities

Currently working on a Euro
25 million european facility
following such a deal

Working on territory competitiveness



September 9th, 2008
: Alsace Biovalley and GE
Healthcare sign a partnership agreement to
create and develop a molecular imaging
plateform



July 3rd, 2008
: The Alsace Biovalley cluster
joins forces with Bruker Biospin to elaborate a
plateform dedicated to small animal imaging




July 1st, 2008
: Alsace Biovalley announces Euro
11 million project for life sciences building
hosting research, scientific expertise and
services

Building a healthcare
shiled

to fight infectious
diseases

> Diagnostic, vaccines

& new therapies, Systems


A unique and broad

approach throughout the

continuum of Cancer

> Prevention, diagnostic,
treatment

Facing the challenges of

tomorrow’s healthcare

> Bio Pharmaceuticals :
from chemistry and
genes towards drugs

> Medical Technologies :
medical and surgical
devices, imaging and
robotics


Strenghtening international positioning
beyond Biovalley: LCF

LCF represents more than
1,200 companies

involving > 80,000 jobs

Clusters approach for Regional
Economic development:


The Alsacian illustration in Life
Sciences



Key learning



At the cluster level


Integration within the territorial eco
-
system is key



Clusters develop by leveraging existing assets & resources



Compensate fragmentation & absorb complexity



Fragmentation = Strong repulsing feature for companies


1 cluster = 1 identity = 1 territorial offer





towards a dynamic of co
-
construction between agencies


Ensure strategic coherence & coordination, avoid duplication and
conflicts



International is accessible




Already the first deals concluded





But territorial anchoring remain key


Only source of legitimacy… and key source of funding


Thank you for your attention